16 results · 31ms · Sources: EU EUDAMED, US FDA

nAbCyte Anti-AAVRh74var HB-FE Assay

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

GENETIC TESTS - OTHER

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

OI-genomic profiling assay

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

IVD GENERAL USE CONSUMABLE DEVICES - OTHER

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

OI-immune profiling assay

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

Anti-AAv9 nAb

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

Anti-AAV6 nAb Assay

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

GENETIC TESTS - OTHER

Device
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·On the market·32 countries

nAbCyte Anti-AAVRh74var HB-FE Assay

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device

Anti-AAV9 nAb Assay

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device

Anti-AAV6 nAb Assay

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device

ApoE Genotype Test

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device

TruSight Oncology 500 LDT Assay (TS0500)

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device

APOL1 Genotyping Test

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device

OI-immune profiling assay

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device

OI-genomic profiling assay

Basic UDI-DI
EU IVDD · Eu Ivd General ·Laboratory Corporation of America Holdings·1 device